Genes and the parsing of cognitive processes

Trends in Cognitive Sciences

Volumn 8, Issue 7, 2004, Pages 325-335

  Goldberg, Terry E ^a   Weinberger, Daniel R ^a  

^a IRP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASSAYS; BEHAVIORAL RESEARCH; BIOMEDICAL ENGINEERING; GENES; MEDICAL IMAGING; NEUROLOGY; NEUROPHYSIOLOGY;

COGNITIVE PROCESSES; MULTIPLE GENES; NEUROIMAGING;

COGNITIVE SYSTEMS;

AMINE OXIDASE (FLAVIN CONTAINING); BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHOL METHYLTRANSFERASE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; NICOTINIC RECEPTOR; SEMAPHORIN; SEROTONIN 2A RECEPTOR;

BRAIN FUNCTION; COGNITION; DNA POLYMORPHISM; DYSLEXIA; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOMICS; HUMAN; LANGUAGE DISABILITY; MEMORY; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; REVIEW; TEMPORAL CORTEX;

ANIMALS; ATTENTION; BRAIN; BRAIN MAPPING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATECHOL O-METHYLTRANSFERASE; COGNITION; GENES; GENOMICS; HUMANS; LANGUAGE; LINKAGE (GENETICS); MAGNETIC RESONANCE IMAGING; MEMORY, SHORT-TERM; MENTAL PROCESSES; NEUROBIOLOGY; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 3042778314     PISSN: 13646613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tics.2004.05.011     Document Type: Review

References (56)

1. Botstein D., Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33:2003;228-237
2. Grantham R. Amino acid difference formula to help explain protein evolution. Science. 185:1974;862-864
3. Bouchard T.J., McGue M. Genetic and environmental influences on human psychological differences. J. Neurobiol. 54:2003;4-45
4. Battaglia A., Carey J.C. Diagnostic evaluation of developmental delay/mental retardation: an overview. Am. J. Med. Genet. 117C:2003;3-14
5. Nussbaum R.L., Ellis C.E. Alzheimer's disease and Parkinson's disease. Eng. J. Med. 14:2003;1356-1364
6. Ross C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron. 35:2002;819-822
7. Xu J., Chen Z. Advances in molecular cytogenetics for the evaluation of mental retardation. Am. J. Med. Genet. 117C:2003;15-24
8. Bennett D.A., et al. Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology. 60:2003;246-252
9. Dik M.G., et al. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology. 54:2000;1492-1497
10. Hariri A.R., Weinberger D.R. Imaging genomics. Br. Med. Bull. 65:2003;259-270
11. Freedman R., et al. Inhibitory neurophysiological deficit as a phenotype for genetic investigation of schizophrenia. Am. J. Med. Genet. 97:2000;58-64
12. Leonard S., et al. Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry. 59:2002;1085-1096
13. Freedman R., et al. Linkage of a neurophysiological deficit in schizophrenia to chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 94:1997;587-592
14. Fossella J., et al. Assessing the molecular genetics of attention networks. BMC Neurosci. 3:2002;14
15. Carson R.P., Robertson D. Genetic manipulation of noradrenergic neurons. J. Pharmacol. Exp. Ther. 301:2002;410-417
16. Fan J., et al. Mapping the genetic variation of executive attention onto brain activity. Proc. Natl. Acad. Sci. U. S. A. 100:2003;7406-7411
17. Gainetdinov R.R., Caron M.G. Monoamine transporters: from genes to behavior. Annu. Rev. Pharmacol. Toxicol. 43:2003;261-284
18. Kluger A.N., et al. A meta-analysis of the association between DRD4 polymorphism and novelty seeking. Mol. Psychiatry. 7:2002;712-717
19. Faraone S.V., et al. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry. 158:2001;1052-1057
20. Maher B.S., et al. Dopamine system genes and attention deficit hyperactivity disorder: a meta-analysis. Psychiatr. Genet. 12:2002;207-215
21. Eisenberg J., et al. Haplotype relative risk study of catechol-O-methyltransferase (COMT) and attention deficit hyperactivity disorder (ADHD): association of the high-enzyme activity val allele with ADHD impulsive-hyperactive phenotype. Am. J. Med. Genet. 88:1999;497-502
22. Loo S.K., et al. Functional effects of the DAT1 polymorphism on EEG measures in ADHD. J. Am. Acad. Child Adolesc. Psychiatry. 42:2003;986-993
23. Swanson J., et al. Attention deficit/hyperactivity disorder with a 7-repeat allele of the dopamine D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4754-4759
24. Robbins T. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp. Brain Res. 133:2000;130-138
25. Weinshilboum R.M., et al. Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyltransferase, and histamine N-methyltransferase. Annu. Rev. Pharmacol. Toxicol. 39:1999;19-52
26. Gogos J.A., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9991-9996
27. Sesack S.R., et al. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivty for the dopamine transporter. J. Neurosci. 18:1998;2697-2708
28. Levy R., Goldman-Rakic P.S. Segregation of working memory functions within dorsolateral prefrontal cortex. Exp. Brain Res. 133:2002;23-32
29. 108/158 met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6917-6922
30. Berman K.F., et al. Physiological activation of a cortical network during performance of the Wisconsin Card Sorting Test: a positron emission tomography study. Neuropsychologia. 33:1995;1027-1046
31. Malhotra A.K., et al. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am. J. Psychiatry. 159:2002;652-654
32. Joober R., et al. Catechol-O-Methyltransferase val-108/158-met gene variants associated with Wisconsin Card Sorting Test. Arch. Gen. Psychiatry. 59:2002;662-663
33. Diamond A., et al. Genetic and neurochemical modulation of prefrontal cognitive functions in children. Am. J. Psychiatry. 16:2004;125-132
34. Bilder R.M., et al. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry. 52:2002;701-707
35. Goldberg T.E., et al. Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch. Gen. Psychiatry. 60:2003;889-896
36. Gallinat J., et al. Assoication of the G1947A COMT (Val 108/158Met) gene polymorphism with prefrontal P300 duing information processing. Biol. Psychiatry. 54:2003;40-48
37. 158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. U. S. A. 100:2003;6186-6191
38. Williams G., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575
39. Egan M.F., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 112:2003;257-269
40. Wilson R.S., et al. Association of memory and cognition in Alzheimer's disease with volumetric estimates of temporal lobe structures. Neuropsychology. 10:1996;459-463
41. 66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci. 23:2003;6690-6694
42. Quervain D.J.-F., et al. A functional genetic variation of the 5HT2a receptor affects human memory. Nat. Neurosci. 6:2003;1141-1142
43. Bailey C.H., et al. A novel function for serotonin mediated short term facilitation in Aplysia. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11581-11586
44. Consortium S.L.I. A genome wide scan identifies two novel loci involved in specific language impairment. Am. J. Hum. Genet. 70:2002;384-398
45. Bartlett C.W., et al. A major susceptibility locus for specific language impairment is located on 13q21. Am. J. Hum. Genet. 71:2002;45-55
46. Stein C.M., et al. Pleiotropic effects of a chromosome 3 locus on speech-sound disorder and reading. Am. J. Hum. Genet. 74:2004;283-297
47. Lai C.S., et al. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 413:2001;519-523
48. Marcus G.F., Fisher S.E. FOXP2 in focus: what can genes tell us about speech and language? Trends Cogn. Sci. 7:2003;257-262
49. Fisher S.E., DeFries J.C. Developmental dyslexia: genetic dissection of a complex cognitive trait. Nat. Rev. Neurosci. 3:2002;767-780
50. Francks C., et al. The genetic basis of dyslexia. Lancet Neurol. 1:2002;483-490
51. Fisher S.E., et al. Independent genome-wide scans identify a chromosome 18 quantitative-trait locus influencing dyslexia. Nat. Genet. 30:2002;86-91
52. Marlow A.J., et al. Use of multivariate linkage analysis for dissection of a complex cognitive trait. Am. J. Hum. Genet. 72:2003;561-570
53. Francks C., et al. Fine mapping of the chromosome 2p12-16 dyslexia susceptibility locus: quantitative association analysis and positional candidate genes SEMA4F and OTX1. Psychiatr. Genet. 12:2002;35-41
54. Mervis C.B. Williams syndrome. Dev. Neuropsychol. 23:2003;1-12
55. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry. 160:2003;636-645
56. Toma D.T., et al. Identification of genes involved in Drosophila melanogaster geotaxis, a complex behavioral trait. Nat. Genet. 31:2002;349-353